Bionano Genomics (BNGO) said Monday it closed a $10 million registered direct offering of shares and warrants to purchase common stock.

The company sold about 39.7 million shares and warrants to purchase an equal amount of shares at $0.252 per share and accompanying warrant.

The warrants have an exercise price of $0.252 per share and will expire five years from the effective date of stockholder approval, the company said.

Bionano said net proceeds from the offering, along with existing cash and cash equivalents and available-for-sale securities, will be used for general corporate purposes, including working capital, research and development expenses, debt repayment and capital costs.